Stock Analiz

Tenon Medical, Inc. TNON

Medical/Dental Instruments · IPO 2022 · data as of November 13, 2026

$1.41Market cap $4M
Open the interactive analysis →

Tenon Medical, Inc. (TNON) is a healthcare company listed in the US with a market value of about $4M. In the twelve months to September 30, 2026 it had revenue of $6M and net income of -$17M, a net margin of -305.1%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -261%.

About Tenon Medical

Tenon Medical is listed in the US and classified in medical/dental instruments, IPO year 2022. Revenue went from $160000 in 2021 to $4M in 2025, growth of about 122.8% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 7267% over three years (dilution for shareholders). It spends 54% of revenue on research and development.

Score: 1.2 / 5

Value0/5
Future growth4/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.7
P/B—
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-290.6%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)20.3%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-1682.1%
ROIC (5-yr avg.)-260.8%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 5 years

Fiscal yearTTM20252024202320222021
Revenue$6M$4M$3M$3M$691000$160000
Net income-$17M-$13M-$14M-$16M-$19M-$7M
Free cash flow—-$11M-$10M-$13M-$13M-$4M
EPS (diluted)$-57.92$-1.70$-11.26$-68.64$-188.75$-623.96
Net margin-305.1%-318.4%-417.2%-532.1%-2737.6%-4405.0%
ROIC—-195.0%-169.9%-471.5%-206.5%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 2 analysts is $8.00, 467% above the current price; targets range from $5.00 to $11.00; the consensus rating is “Strong buy”; expected EPS is $-15.46 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does Tenon Medical pay a dividend?

Not currently.

Is Tenon Medical a good stock to buy?

We do not give buy or sell advice. Tenon Medical scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.